Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.
作者： Kazunari Yoshida , Daniel J. Müller
DOI: 10.1159/000492332
关键词: Antipsychotic drug 、 MEDLINE 、 Schizophrenia 、 Intensive care medicine 、 Adverse effect 、 Pharmacogenomics 、 Pharmacogenetics 、 Antipsychotic 、 Medicine 、 Movement disorders
摘要: … that included studies through the end of 2014 found that 13 SNPs from nine genes were significantly associated with AIWG, with the SNPs in adrenoreceptor alpha 2A (ADRA2A), DRD2…
karger.com
sci-hub.se 参考文章(151)
Carhart Jm, Winner Jg, Allen Jd, Dechairo Bm, Altar Ca, A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder. Discovery Medicine. ,vol. 16, pp. 219- ,(2013)
Jennie G Pouget, Arun K Tiwari, Daniel J Müller, Tahireh A Shams, Pharmacogenetics and outcome with antipsychotic drugs. Dialogues in clinical neuroscience. ,vol. 16, pp. 555- 566 ,(2014)
Stefano Porcelli, Soo-Jung Lee, Changsu Han, Ashwin A. Patkar, Alessandro Serretti, Chi-Un Pae, CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study. Psychiatric Genetics. ,vol. 25, pp. 163- 167 ,(2015) , 10.1097/YPG.0000000000000092
Licai Dong, Hao Yan, Xuebing Huang, Xiaofeng Hu, Yongfeng Yang, Cuicui Ma, Bo Du, Tianlan Lu, Chao Jin, Lifang Wang, Hao Yu, Zheng Dong, Wenqiang Li, Yanyan Ruan, Hongyan Zhang, Hongxing Zhang, Weifeng Mi, Wenbin Ma, Keqing Li, Luxian Lv, Dai Zhang, Weihua Yue, A2BP1 gene polymorphisms association with olanzapine-induced weight gain. Pharmacological Research. ,vol. 99, pp. 155- 161 ,(2015) , 10.1016/J.PHRS.2015.06.003
S Le Clerc, L Taing, G Fond, A Meary, P-M Llorca, O Blanc, P Beaune, K Rajagopal, S Jamain, R Tamouza, J-F Zagury, M Leboyer, A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia Translational Psychiatry. ,vol. 5, ,(2015) , 10.1038/TP.2015.97
Q Xu, X Wu, M Li, H Huang, C Minica, Z Yi, G Wang, L Shen, Q Xing, Y Shi, L He, S Qin, Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population. Pharmacogenomics Journal. ,vol. 16, pp. 357- 365 ,(2016) , 10.1038/TPJ.2015.61
Po-Yu Chen, Mong-Liang Lu, Ming-Chyi Huang, Chung-Feng Kao, Po-Hsiu Kuo, Chih-Chiang Chiu, Shih-Ku Lin, Chun-Hsin Chen, The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia. Journal of Clinical Psychopharmacology. ,vol. 35, pp. 574- 578 ,(2015) , 10.1097/JCP.0000000000000386
Tadafumi Kato, Whole genome/exome sequencing in mood and psychotic disorders. Psychiatry and Clinical Neurosciences. ,vol. 69, pp. 65- 76 ,(2015) , 10.1111/PCN.12247
Ramón Cacabelos, Ryota Hashimoto, Masatoshi Takeda, Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry and Clinical Neurosciences. ,vol. 65, pp. 3- 19 ,(2011) , 10.1111/J.1440-1819.2010.02168.X
C Zhang, Y Zhang, J Cai, M Chen, L Song, Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis Pharmacogenomics Journal. ,vol. 17, pp. 92- 97 ,(2017) , 10.1038/TPJ.2015.68